MedTrace Logo

Alpha Lipoic Acid and Chronic Lumbosacral Radicular Pain

NCT03428139 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-02-09

No results posted yet for this study

Summary

In this study, we try to evaluate the effect of using ALA as an adjuvant treatment in patients scheduled for pulsed radiofrequency treatment (PRFT) of the affected dorsal root ganglion (DRG) for treatment of Lumbo-Sacral radicular pain.

Conditions

  • Radicular; Neuropathic, Lumbar, Lumbosacral

Interventions

PROCEDURE

pulsed radiofrequency

Each patient in this group was treated with PRFT on the affected DRG at 42°C for 120 seconds.

DRUG

pulsed radiofrequency plus alpha lipoic acid

Each patient in this group was treated with PRFT as in group I plus oral alpha lipoic acid (ALA) 600 mg (Thiotacid 600 mg, EVA PHARMA, Egypt) three times per day (1800mg/day) for 3 weeks then 600mg once daily for 2 weeks.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Abdelrady S Ibrahim, M.D. · Assiut University faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-20
Primary Completion
2017-03-03
Completion
2017-09-08

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428139 on ClinicalTrials.gov